Fatty Change and Metabolic Syndrome Quiz
42 Questions
3 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is a characteristic biochemical finding for diagnosing hemochromatosis?

  • Decreased total iron binding capacity
  • Presence of granulomas in the liver
  • Ferritin level exceeding 500 ng/mL
  • Transferrin saturation greater than 55% (correct)
  • Which of the following treatments is considered effective for Primary Biliary Cholangitis (PBC)?

  • Steroids
  • Antibiotics for cholangitis
  • Ursodeoxycholic acid (UDCA) (correct)
  • Liver transplant as a first-line treatment
  • What is a common association found in patients with Primary Sclerosing Cholangitis (PSC)?

  • Presence of metabolic syndrome
  • Chronic liver failure
  • Autoimmune hepatitis
  • Ulcerative colitis (UC) (correct)
  • In the assessment of ferritin levels, which statement is true regarding its specificity for diagnosing hemochromatosis?

    <p>Ferritin is sensitive but not very specific due to inflammation.</p> Signup and view all the answers

    What is a potential risk in patients with extrahepatic disease in Primary Sclerosing Cholangitis (PSC)?

    <p>Ascending cholangitis</p> Signup and view all the answers

    What is the most common genetic mutation associated with hereditary haemochromatosis?

    <p>C282Y</p> Signup and view all the answers

    Which organ is primarily affected by iron deposition leading to cirrhosis?

    <p>Liver</p> Signup and view all the answers

    What is the function of hepcidin in iron metabolism?

    <p>Regulates iron exporter degradation</p> Signup and view all the answers

    Which of the following statements about hereditary haemochromatosis is true?

    <p>It has a penetrance rate of 60% for clinical effects.</p> Signup and view all the answers

    Which of these complications is associated with iron overload in the endocrine pancreas?

    <p>Secondary diabetes mellitus</p> Signup and view all the answers

    What is the role of the HFE gene in iron metabolism?

    <p>Regulates hepcidin synthesis</p> Signup and view all the answers

    What is one of the rare forms of hereditary haemochromatosis?

    <p>Non-HFE gene-associated</p> Signup and view all the answers

    Which of the following describes secondary haemochromatosis?

    <p>It can result from multiple blood transfusions.</p> Signup and view all the answers

    What characterizes macrovesicular fatty change in hepatocytes?

    <p>Presence of a single large droplet</p> Signup and view all the answers

    Which of the following is NOT a common cause of macrovesicular fatty change?

    <p>Acute fatty liver of pregnancy</p> Signup and view all the answers

    Which risk factor is NOT part of the metabolic syndrome diagnostic criteria?

    <p>Liver enzyme levels beyond normal range</p> Signup and view all the answers

    How is microvesicular fatty change typically defined?

    <p>Presence of multiple small droplets within hepatocytes</p> Signup and view all the answers

    What indicates the need for antihypertensive medication in the context of metabolic syndrome?

    <p>Blood pressure greater than 130/85 mm Hg</p> Signup and view all the answers

    Which condition is associated with microvesicular fatty change?

    <p>Acute fatty liver of pregnancy</p> Signup and view all the answers

    What is a key characteristic of cirrhosis?

    <p>Fibrosis and scar tissue formation</p> Signup and view all the answers

    Which of the following statements is correct regarding fatty liver disease?

    <p>Can result from metabolic syndrome and obesity</p> Signup and view all the answers

    What is a clinical feature that differentiates Primary Sclerosing Cholangitis (PSC) from Primary Biliary Cholangitis (PBC)?

    <p>Obstruction of the common bile duct</p> Signup and view all the answers

    How does hepcidin contribute to the anemia seen in chronic disease?

    <p>By inhibiting iron release from macrophages</p> Signup and view all the answers

    What is a key diagnostic criteria for hereditary hemochromatosis when transferrin saturation levels are considered?

    <p>Transferrin saturation levels &gt; 55%</p> Signup and view all the answers

    Which of the following is associated with Primary Biliary Cholangitis treatment outcomes?

    <p>Use of Ursodeoxycholic acid (UDCA)</p> Signup and view all the answers

    In the context of Primary Sclerosing Cholangitis, what is the association found with inflammatory bowel disease (IBD)?

    <p>IBD is present in 70% of patients with PSC</p> Signup and view all the answers

    What primary factor contributes to hereditary haemochromatosis?

    <p>Specific defect in the HFE gene</p> Signup and view all the answers

    How does HFE gene mutation primarily affect iron metabolism?

    <p>It positively regulates hepcidin synthesis.</p> Signup and view all the answers

    What is a common symptom associated with iron overload in haemochromatosis?

    <p>Secondary diabetes mellitus</p> Signup and view all the answers

    In terms of genetic inheritance, how is hereditary haemochromatosis primarily classified?

    <p>Autosomal recessive</p> Signup and view all the answers

    Which statement about the penetrance of HFE gene mutations is correct?

    <p>It has a high penetrance of 30-50% for genetic change.</p> Signup and view all the answers

    What is the role of hepcidin in iron metabolism?

    <p>It degrades ferroportin to regulate iron efflux.</p> Signup and view all the answers

    Which organ is primarily affected by fibrosis and cirrhosis due to iron deposition?

    <p>Liver</p> Signup and view all the answers

    Which of the following best describes a potential complication linked to iron overload in haemochromatosis?

    <p>Dilated cardiomyopathy</p> Signup and view all the answers

    What is the defining characteristic of macrovesicular fatty change in hepatocytes?

    <p>Presence of a single large droplet in the cytoplasm</p> Signup and view all the answers

    Which of the following factors is NOT considered a risk factor for metabolic syndrome?

    <p>Cholesterol level above 200 mg/dL</p> Signup and view all the answers

    Which condition is associated with microvesicular fatty change?

    <p>Acute fatty liver of pregnancy</p> Signup and view all the answers

    What does metabolic syndrome require an individual to have?

    <p>At least three of five specified risk factors</p> Signup and view all the answers

    What is typically described as a reversible cellular change associated with metabolic response?

    <p>Macrovesicular fatty change</p> Signup and view all the answers

    Which of the following describes the condition known as hereditary hemochromatosis (HFE)?

    <p>A genetic disorder leading to excessive iron accumulation</p> Signup and view all the answers

    Which statement correctly describes the influence of alcohol on the liver?

    <p>Alcohol can lead to both fatty liver disease and cirrhosis</p> Signup and view all the answers

    What distinguishes microvesicular fatty change from macrovesicular fatty change?

    <p>Size and number of lipid droplets within the hepatocyte cytoplasm</p> Signup and view all the answers

    Study Notes

    Fatty Change

    • Fatty change is a reversible cellular change, a metabolic response.
    • Macrovesicular fatty change is the most common type; it involves a single large droplet of fat within the hepatocyte cytoplasm.
    • Microvesicular fatty change is rare and associated with acute liver failure.
    • Causes of macrovesicular fatty change include alcohol, metabolic syndrome, starvation, bariatric surgery, total parenteral nutrition (TPN), and amiodarone.

    Metabolic Syndrome

    • Metabolic syndrome is characterized by at least three of five risk factors: abdominal obesity, hypertension, elevated fasting blood glucose, high triglycerides, and low HDL cholesterol.

    Haemochromatosis

    • Haemochromatosis is caused by excessive iron deposition in tissues, leading to damage.
    • Hereditary haemochromatosis is characterized by progressive iron absorption exceeding body needs.
      • Most cases are associated with a specific genetic defect in the HFE gene.
      • Rarely, non-HFE gene-associated hereditary haemochromatosis can occur.
    • Secondary haemochromatosis results from iron overload due to multiple transfusions or ineffective erythropoiesis in hereditary anaemias (e.g., thalassaemia).

    Genetics of Hereditary Haemochromatosis

    • Hereditary haemochromatosis is an autosomal recessive disorder linked to the HFE gene on chromosome 6p.
    • The C282Y and H63D mutations are most common.
    • Most HFE cases are C282Y/C282Y homozygotes, while 60% of C282Y/H63D heterozygotes are at risk.
    • The genetic change is more prevalent than phenotypic evidence of iron overload due to incomplete penetrance (30-50%) and clinical effects (10-30%).
    • Screening first-degree relatives is recommended if a mutation is identified.

    Haemochromatosis: Effects on the Body

    • Iron deposition can damage various organs including:
    • Liver (fibrosis and cirrhosis)
    • Endocrine pancreas (secondary diabetes mellitus)
    • Myocardium (dilated cardiomyopathy)
    • Anterior pituitary (secondary hypogonadism and impotence)
    • Joints (arthropathy)
    • Symptoms may include: Fatigue, skin hyperpigmentation ("bronze diabetes").
    • Symptoms are rare, and often develop later in life.

    Iron Metabolism

    • Dietary iron is absorbed by duodenal enterocytes and only a small amount is released to compensate for non-specific losses.
    • Iron is transported in the blood by transferrin, and its saturation percentage indicates iron storage status.
    • Excess iron is stored in hepatocytes and can be mobilized to plasma during iron deficiency.
    • Iron efflux from macrophages, enterocytes, or hepatocytes is negatively regulated by hepcidin, a liver-derived hormone.
    • Hepcidin binds to ferroportin, an iron exporter, and promotes its degradation, effectively reducing iron release from cells.
    • HFE positively regulates hepcidin synthesis.
    • Prolonged inflammatory stimulation of hepcidin can lead to anaemia of chronic disease.

    Diagnosis of Haemochromatosis

    • Biochemistry:
      • High transferrin saturation level (iron/transferrin levels expressed as percentage) above 55% is significant.
      • Ferritin level is sensitive but less specific.
        • It acts as an acute phase reactant and is associated with inflammation.
        • Useful for follow-up.
      • Hereditary haemochromatosis can be excluded when transferrin saturation is below 30% and serum ferritin levels are less than 100 micrograms/L.

    Primary Biliary Cholangitis (PBC)

    • It was formerly called Primary Biliary Cirrhosis.
    • Cirrhosis is the end stage of the disease, but many patients present without symptoms.
    • Treatment includes:
      • Ursodeoxycholic acid (UDCA) – responders may have no excess mortality.
      • Liver transplantation can be considered in advanced disease.

    Primary Sclerosing Cholangitis (PSC)

    • This is a chronic inflammatory condition leading to a fibro-obliterative destruction of bile ducts.
    • It can affect intrahepatic and/or extrahepatic ducts, commonly both.
    • If mainly intrahepatic, it presents as progressive cholestasis with clinical features similar to PBC, eventually leading to cirrhosis.
    • If mainly extrahepatic, it manifests as a stricture with common bile duct obstruction, increasing the risk of ascending cholangitis.
    • It is four times more common in females than in males.
    • Strong association with IBD (Inflammatory Bowel Disease), especially ulcerative colitis (present in 70% of PSC patients).
    • PSC is less common than PBC.
    • Characterized by positive p-ANCA and negative AMA (Anti-mitochondrial antibodies)

    Fatty Change

    • Hepatocytes can accumulate fat in the form of droplets, categorized as macrovesicular or microvesicular, depending on the size and number of droplets.
    • Macrovesicular fatty change, marked by single, large droplets, is the most common type and often reversible. It's associated with alcohol consumption, metabolic syndrome, starvation, bariatric surgery, total parenteral nutrition (TPN), and amiodarone.
    • Microvesicular fatty change is rare, characterized by small droplets, and reflects a severe metabolic disruption in hepatocyte mitochondria. It's implicated in acute liver failure, acute fatty liver of pregnancy, and tetracycline toxicity.

    Metabolic Syndrome

    • Metabolic syndrome is a cluster of risk factors that increase the likelihood of developing cardiovascular disease and type 2 diabetes.
    • To be diagnosed with metabolic syndrome, an individual must exhibit at least three of five risk factors:
      • Abdominal obesity (waist circumference greater than 40 inches in men and 35 inches in women).
      • Hypertension (blood pressure greater than 130/85 mmHg, or requiring antihypertensive medication).
      • Elevated fasting blood glucose (greater than 100 mg/dL or requiring medication for hyperglycemia).
      • High triglyceride levels (greater than 150 mg/dL, or requiring treatment for elevated triglycerides).
      • Low HDL cholesterol (less than 40 mg/dL in men and 50 mg/dL in women).

    Haemochromatosis

    • Haemochromatosis is a condition characterized by excessive iron deposition in tissues, leading to cellular damage.
    • Hereditary haemochromatosis is caused by a genetic defect in the HFE gene, resulting in increased iron absorption.
    • Secondary haemochromatosis arises from iron overload due to multiple transfusions or conditions like thalassemia, which lead to ineffective erythropoiesis.

    Genetics of Hereditary Haemochromatosis

    • Hereditary haemochromatosis is an autosomal recessive disorder, with mutations in the HFE gene located on chromosome 6p.
    • The most common mutations are C282Y and H63D, with most cases being homozygous for the C282Y mutation.
    • Approximately 60% of individuals heterozygous for both C282Y and H63D are at risk.
    • Genetic mutations are prevalent, but not all carriers develop iron overload, with a penetrance rate of 30-50% overall. Only approximately 10-30% experience clinical effects, making biochemical iron overload more common than overt disease.

    Haemochromatosis: Clinical Consequences

    • Iron overload can damage various organs, causing a range of health problems:
      • Liver damage (fibrosis and cirrhosis)
      • Endocrine pancreas damage (secondary diabetes mellitus)
      • Heart damage (dilated cardiomyopathy)
      • Anterior pituitary damage (secondary hypogonadism and impotence)
      • Arthropathy
      • Fatigue
      • Skin hyperpigmentation (bronze diabetes)

    Iron Metabolism

    • Dietary iron is absorbed in the duodenum by enterocytes and released in small amounts to offset nonspecific losses.
    • Transferrin transports iron in the bloodstream, with iron saturation reflecting iron storage levels.
    • Hepatocytes store excess iron, which can be mobilized back into the plasma during iron deficiency.
    • Iron efflux from macrophages, enterocytes, or hepatocytes is regulated by hepcidin, a liver-derived hormone. Hepcidin binds to ferroportin, an iron exporter, promoting its degradation and controlling iron release.
    • The HFE protein positively regulates hepcidin synthesis.

    Diagnosis of Haemochromatosis

    • Clinical features and laboratory findings are used to diagnose haemochromatosis:
      • Biochemical tests:
        • High percentage saturation of transferrin (>55% is significant).
        • Elevated ferritin levels, which are sensitive but less specific, as ferritin is an acute phase reactant and can be elevated in inflammation.

    Primary Biliary Cholangitis (PBC)

    • Formerly known as Primary Biliary Cirrhosis, PBC describes a chronic, autoimmune disease that primarily affects the intrahepatic bile ducts.
    • Initially, the disease may be asymptomatic, with slow disease progression.
    • Cirrhosis is a late-stage manifestation of the disease.
    • Treatment options include:
      • Ursodeoxycholic acid (UDCA), which may improve survival in responders.
      • Steroids are not effective.
      • Symptomatic management.
      • Liver transplantation can be considered.

    Primary Sclerosing Cholangitis (PSC)

    • PSC is a chronic inflammatory disorder involving the intrahepatic and/or extrahepatic bile ducts, often both.
    • The destruction of bile ducts leads to progressive cholestasis, a state of reduced bile flow.
    • When mainly intrahepatic, features resemble PBC, progressing to cirrhosis.
    • When mainly extrahepatic, it manifests as strictures and obstruction of the common bile duct, increasing the risk of ascending cholangitis.
    • PSC occurs four times more frequently in women and is less common than PBC.
    • PSC is strongly associated with inflammatory bowel disease (IBD), especially ulcerative colitis, which is present in approximately 70% of PSC patients.
    • PSC is associated with positive p-ANCA antibodies but negative AMA antibodies.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Description

    Test your knowledge on fatty change, metabolic syndrome, and haemochromatosis. This quiz covers the causes, types, and associated conditions of these metabolic disorders. Enhance your understanding of liver function and iron metabolism.

    More Like This

    Fatty Change
    10 questions

    Fatty Change

    HeroicRainbow avatar
    HeroicRainbow
    Fatty Change (Steatosis) Quiz
    15 questions
    Fatty Change (Steatosis) Quiz
    35 questions
    Use Quizgecko on...
    Browser
    Browser